Objectives: To establish whether the ingestion of diets enriched with olive oil or high-oleic sun¯ower oil may produce changes in the composition of VLDL triacylglycerols from hypertensive patients. It could be relevant for the uptake and metabolism of triacylglycerol-derived metabolites by extrahepatic tissues. Design: Patients were assigned to the diets in a random-order sequence. Subjects: The participants were 24 hypertensive patients recruited from a religious community. Interventions: The study was conducted over two four week periods with a four week washout period between both MUFA diets. Results: Dietary olive oil kept in balance the content of saturated fatty acids and decreased the content of arachidonic acid in VLDL triacylglycerols. HOSO diet reduced the content of palmitic acid and increased the content of linoleic acid. There was also a decrease in trioleate-glycerol and an increase in tripalmitate-glycerol of VLDL after the MUFA diets, but these effects were more pronounced in the HOSO group. Intake of olive oil decreased the content of disaturated triacylglycerols and increased the content of dioleate-containing triacylglycerols. A decrease in palmitate-dioleate-glycerol after dietary HOSO was observed. Olive oil (but not HOSO) promoted the presence of long-chain PUFA of n-3 family at the sn-2 position of VLDL triacylglycerols. Conclusions: Our data indicate that olive oil and HOSO, providing a similar concentration of MUFA (oleic acid), differ in the formation of VLDL triacylglycerols in hypertensive patients. Sponsorship: This study was supported by a grant (ALI96-0456 and OLI96-2126) from the CICYT, Spain.
Introduction
Recommendations to intake monounsaturated fatty acids (MUFA)-rich oils were one of the emergent strategies in the last years for modulating the plasma lipid pro®le in humans (Heyden, 1994; Katan et al, 1994) . Accordingly, the so-called Mediterranean diet with a high content of MUFA is actually associated with a low incidence of coronary heart disease (CHD) (Keys et al, 1986) .
Olive oil contains a high amount of MUFA (mainly oleic acid (18:1 n-9)) and predominates in Mediterranean dietary patterns. Diets supplemented with olive oil are reported to have bene®cial effects on plasma lipids and lipoprotein pro®le in hyperlipidaemic patients (Nydahl et al, 1994) , but the effects on healthy subjects are still controversial (Truswell & Choudhury, 1998) . In addition, recent studies have shown that not only olive oil but also high-oleic sun¯ower oil (HOSO) may reduce the risk for CHD, both oils having a similar effect in diminishing the atherogenic index (total cholesterolaHDL cholesterol) and the LDL : HDL cholesterol ratio in the plasma of normocholesterolaemic and hypercholesterolaemic hypertensive patients (Ruiz-Gutierrez et al, 1998a) . However, olive oil but not HOSO had in¯uence on the normalising of structural and functional alterations of erythrocyte cell membrane in patients affected with essential hypertension (Muriana et al, 1997a, b) . This raises the question of whether other lipoproteins rather than LDL and HDL cholesterol are important in regulating cellular processes when blood pressure is higher than normal.
Indeed, there are increasing evidences that relate premature CHD and the metabolism of triacylglycerol-rich lipoproteins (Ginsberg et al, 1995; Criqui, 1998) . Among this heterogeneous group of large lipoprotein particles, VLDL are secreted mainly by the liver and their chief function is the transport of endogenously synthesised triacylglycerols into extrahepatic tissues (Thompson, 1994) . Formation of remnant particles and conversion of VLDL to LDL are dependent upon removal of triacylglycerol core molecules by lipolytic pathways, such as those mediated by hepatic lipase and lipoprotein lipase, targeting cells with fatty acids for either energy or storage (Deckelbaum et al, 1992) . The fatty acid pattern of triacylglycerols in VLDL appears to be in¯uenced by the fatty acid composition of dietary fats, so that the metabolic fates of VLDL and the clearance of triacylglycerols may be markedly altered (Campos et al, 1995; Montalto & Bensadoun, 1993) . However, the effects of dietary triacylglycerols on the composition of VLDL in hypertensive patients are unknown.
Interestingly, olive oil and HOSO may contain similar amounts of MUFA (oleic acid) but the oils differ in their triacylglycerol composition (Perez-Jimenez et al, 1995; Carelli & Cert, 1993) . More importantly, olive oil but not HOSO may reduce the systolic and diastolic blood pressures in healthy subjects (Ruiz-Gutierrez et al, 1997) and hypertensive patients (Ruiz-Gutierrez et al, 1996) . These observations suggest a possible link between dietary triacylglycerols and the mechanisms involved in the regulation of blood pressure. In this present study, we focus our investigation on determining the effects of olive oil and HOSO intake on triacylglycerol composition of VLDL from plasma of patients affected with essential hypertension. Total fatty acid composition and sn-2 positional distribution of fatty acids in VLDL triacylglycerols were also evaluated.
Methods

Subjects, experimental design and diets
Twenty-four hypertensive volunteers aged 55.7 AE 3.6 y were recruited for this study (Table 1 ). The criterion for hypertension was a systolic blood pressure !140 mmHg and a diastolic blood pressure !90 mmHg recorded on at least three different occasions after the subject had rested supine for 10 min. Before enrolment, all participants had a comprehensive review of their medical history, as well as physical examination and a clinical chemistry analysis to exclude the possibility of any secondary cause of hypertension. None of them had diabetes mellitus, hypothyroidism or received any antihypertensive drug or another treatment affecting lipid metabolism. No history of alcohol abuse or cigarette smoking was detected. All subjects gave their informed consent before participating in the study.
The study was conducted over two four week periods, during which each participant ate olive oil or HOSO diets, including a washout (four week) period between the two MUFA diets. Assignment was in a random order sequence and in a crossover design. The washout period was long enough to ensure the re-establishment of basal conditions. The study included an initial 28 d period during which all participants consumed a similar diet (baseline) that contained 30% of energy as fat (11% saturated fatty acids (SFA), 16% MUFA and 3% PUFA), 22% as protein and 48% as carbohydrate. Olive oil and HOSO diets were characterised by a lower amount of SFA (6%) and a higher amount of MUFA (21%). The consumption of olive oil and HOSO was $ 50 gad, indicating that both oils contributed around 75% of total dietary fat. The daily energy consumption of participants was $ 9.1 MJ. Dietary cholesterol intake was maintained during the three diet periods at 280 ± 300 mgad. Dietary instructions were given by a dietitian before entry into the study. Each participant was told what food items should be eaten for breakfast, lunch, dinner, and in-between meals. No other food items except mineral water, coffee, and tea were allowed to be consumed during the study periods. Three duplicate food portions corresponding to each weekday were collected and homogenised to be analysed for their fat content and other nutrient. Different menus were prepared as previously described (Perez-Jimenez et al, 1995) . Virgin olive oil (Olea europaea, Extra, Baena, Spain) or HOSO (Helianthus annuus, Coreysa, Seville, Spain) was used for cooking and salad dressing and was occasionally spread on bread slices. To avoid any isomerisation, only oils obtained after the ®rst frying were used. Fatty acid composition, triacylglycerols and fatty acids at sn-2 position of the oils are depicted in Tables 2 and 3 .
Blood sampling and biochemical determinations During the last days of each period, blood samples were obtained from fasting (12 h) patients by venous puncture into EDTA-containing (1 gaL) tubes. Plasma was separated by centrifugation at 15006g at 4 C for 30 min. Lipoprotein fractions were isolated from fresh plasma samples by centrifugation at 105 0006g at 4 C for 20 h with the use of sequential¯otation (Schumaker & Puppione, 1986) . VLDL were harvested at density 1.006 kgaL (Havel et al, 
Incorporation of dietary triacylglycerols
Compliance with the diets was determined by evaluation of daily food questionnaires and by analysis of fatty acid composition of the cholesterol ester fraction in LDL (Sarkkinen et al, 1994) .
Separation of triacylglycerols from VLDL
Lipids from VLDL were extracted with chloroformamethanol (2:1, vav) and separated by TLC on silica gel 60 plates using a solvent system of hexanea diethyletheraacetic acid (80:20:1, vavav). The band corresponding to triacylglycerols was scraped off and eluted with hexaneachloroform (9:1, vav).
Analysis of fatty acid methyl esters
Triacylglycerols were saponi®ed by heating for 10 min with 0.2 molaL sodium methylate at 80 C. Fatty acid methyl esters were formed by heating again for 5 min with 60 gaL H 2 SO 4 in anhydrous methanol. After extraction with hexane, fatty acid methyl esters were analysed in a Hewlett ± Packard 5890 series II gas chromatograph (Hewlett ± Packard Co., Avondale, Pennsylvania, USA) equipped with a¯ame ionisation detector and using an Omegawax 320 fused-silica capillary column (30 m60.32 mm i.d., 0.25 mm ®lm). The initial column temperature was 200 C, which was held for 10 min, then programmed to change from 200 ± 230 C at 2 Camin. The injection and detector temperatures were 250 and 260 C, respectively. The¯ow rate of helium was 2 mLamin. Peak areas were calculated by a Hewlett ± Packard 3390A recording integrator. Individual fatty acid methyl esters were identi®ed by comparison of their retention times with those of reference standards. Fatty acid methyl esters for which no standard was available were quanti®ed using calibration tables of relative response ratios constructed according to carbon number with the use of gas chromatography-mass spectrometry, performed on a Konik KNK-2000 chromatograph (Konik Co., Barcelona, Spain) interfaced directly to an AEJ MS30a70 VG mass spectrometer (VG Analytical, Manchester, UK), using the electron impact ionisation mode. The ion source temperature was maintained at 200 C, the multiplier voltage was 4.0 kV, the emission current was 100 mA and the electron energy was 70 eV. The data were processed with a VG 11a250 data system.
Analysis of triacylglycerols
Fractions of triacylglycerols were redisolved in hexane and analysed in a Chrompack CP9000 gas chromatograph (Chrompack, Middleburg, The Netherlands) ®tted with ā ame ionisation detector and a split injection system (splitting ratio 1:30) (Carelli & Cert, 1993; Ruiz-Gutierrez & Barron, 1995) . Separation was conducted on a high temperature aluminium-clad fused-silica capillary column (25 m60.25 mm i.d.) coated with methyl 65% phenylsilicone (0.1 mm ®lm). The initial column temperature was 350 C, which was held for 1 min, then programmed to change from 350 ± 360 C at 0.5 Camin and remaining at 360 C for 8 min. The injection and detector temperatures were 360 and 365 C, respectively. Helium was used as the carrier gas at a column head pressure of 130 kPa. Trilinolein, trimyristin, trinonadecanoin, triolein, palmitatedioleate-sn-glycerol, tripalmitin, tripalmitolein and tristearin were used as reference standards (Nu-Chek-Prep Inc., Elysian, Minnesota, USA). Tripentadecanoin was used as internal standard (Sigma-Aldrich Quimica SA, Madrid, Spain). Triacylglycerols were then identi®ed by their elution times, their expected elution orders and by comparison with previous studies (Ruiz-Gutierrez et al, 1992a, b) , because retention is affected not only by the number of carbon atoms but also by the number of double bonds.
Fatty acids in the sn-2 position of triacylglycerols Triacylglycerols were partially hydrolysed by pancreatic lipase from pig (EC 3.1.1.3; Sigma-Aldrich Quimica SA) and then separated by TLC on silica gel 60 plates by using a solvent system of hexaneadiethyletheraacetic acid (60:40:2, vavav) (Ruiz-Gutierrez & Mazuelos 1985) . The band corresponding to monoacylglycerols was scraped off, eluted with hexane and treated as above for analysis of fatty acid methyl esters.
Blood pressure measurements
Blood pressure measurements were performed at the right brachial artery of participants using a mercury-gauge sphygmomanometer. At each visit three blood pressure readings were recorded and the average was used to determine eligibility. In addition, blood pressure was recorded at the beginning and end of each period of MUFA diet.
Statistical analyses
The signi®cance of the differences between the groups was assessed by one-way (repeated measures) ANOVA with Tukey's post-hoc comparison of the means (Neter et al, 1985) . Data were transformed reciprocally before statistical analysis. All comparisons were considered statistically signi®cant at P`0.05. The analyses were done with the GraphPAD InStat (GraphPAD Software, San Diego, California, USA) and CoStat (CoHort Software, Berkeley, California, USA) statistical packages.
Results
Diets
Compliance with the diets was estimated to be higher than 90% from the evaluation of daily food questionnaires and by analysis of the fatty acid composition of the plasma cholesterol ester fraction of LDL during ingestion of olive oil and HOSO diets (Sarkkinen et al, 1994) , indicating a good adherence to the diets.
The fatty acid composition of olive oil and HOSO was characterised by a high content of MUFA (mainly oleic Incorporation of dietary triacylglycerols V Ruiz-Gutierrez et al acid (18:1 n-9) (80% of total fats)) ( Table 2) . Palmitic acid ((16:0) 75% of total SFA) and a-linolenic acid ((18:3 n-3) 15% of total PUFA) were more abundant in olive oil than in HOSO, whereas the content of linoleic acid (18:2 n-6) was greater in HOSO (9% of total fats) than in olive oil (3% of total fats). Trioleate-sn-glycerol (OOO) was the major triacylglycerol found in HOSO (63% of total triacylglycerols), whereas OOO (46% of total triacylglycerols) and palmitate-dioleate-glycerol ((POO) 30% of total triacylglycerols) were signi®ed as abundant in olive oil (Table 2) . Oleic acid was the predominant fatty acid located at the sn-2 position of triacylglycerols in both olive oil and HOSO ( Table 3) . As in a previous study (Ruiz-Gutierrez et al, 1996) , there was a signi®cant reduction of systolic and diastolic blood pressures in hypertensive patients after olive oil ingestion (data not shown).
Fatty acid composition of VLDL triacylglycerols
With regard to baseline, olive oil diet resulted in signi®cant increases in lauric acid ((12:0), b 100%, P`0.001), myristic acid ((14:0), b 100%, P`0.001), palmitoleic acid ((16:1 n-9), 65%, P`0.001), stearic acid ((18:0), 21%, P`0.01), oleic acid (15%, P`0.001), octadecatetraenoic acid ((18:4 n-3), b 100%, P`0.001), arachidic acid ((20:0), b 100%, P`0.001) and eicosenoic acid ((20:1 n-9), b 100%, P`0.001) of VLDL triacylglycerols (Table  4) , and in signi®cant decreases in palmitic acid (18%, P`0.001), hexadecenoic acid ((16:1 n-7), 41%, P`0.001), a-linolenic acid (24%, P`0.001), eicosatrienoic acid ((20:3 n-6), 22%, P`0.001) and arachidonic acid ((20:4 n-6), 40%, P`0.001). Therefore, the ingestion of olive oil tended to increase MUFA and to decrease PUFA of n-6 family, but kept in balance the content of SFA and PUFA of n-3 family in VLDL triacylglycerols of patients with essential hypertension.
HOSO diet had similar effects as the olive oil diet when compared with baseline, except that linoleic acid (18:2 n-6) was signi®cantly increased (21%, P`0.001), palmitic acid was more markedly decreased (58%, P`0.001) and arachidonic acid was unchanged (Table 4) . These ®ndings were consistent with an increase in MUFA and PUFA of n-6 family, and a decrease in SFA.
Triacylglycerol composition of VLDL Olive oil and HOSO diets signi®cantly decreased the content of trioleate-glycerol (OOO, 64% for olive oil and 71% for HOSO, P`0.001) and increased the content of tripalmitate-glycerol (PPP, 73% for olive oil and b 100% for HOSO, P`0.001) in VLDL of hypertensive patients (Table 5 ). Intake of olive oil, in particular, signi®cantly decreased the content of disaturated triacylglycerols (linoleate-dimirystate-glycerol (MLM, 39%, P`0.001) and oleate-dipalmitate-glycerol (POP) plus palmitatelinoleate-stearate-glycerol (PLS) (29%, P`0.001)) and increased the content of dioleate-containing triacylglycerols (palmitate-dioleate-glycerol (POO, 16%, P`0.001), linoleate-dioleate-glycerol (OLO, 25%, P`0.05)). 3 Nomenclature of fatty acids: M, myristic acid, tetradecanoic acid, 14:0; P, palmitic acid, hexadecanoic acid, 16:0; O, oleic acid, cis-9 octadecenoic acid, 18:1 n-9; L, linoleic acid, cis-9, 12 octadecadienoic acid, 18:2 n-6; S, stearic acid, octadecanoic acid, 18:0; Po, palmitoleic acid, cis-9 hexadecenoic acid, 16:1 n-9. 
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Contrary to olive oil diet, the HOSO diet produced a signi®cant decrease (15%, P`0.05) in palmitate-dioleateglycerol.
Fatty acids at the sn-2 position of VLDL triacylglycerols Both oils contributed to VLDL enriched in palmitoleic acid (16:1 n-9, b 100%, P`0.001) and oleic acid (18:1 n-9, 20%, P`0.01) but depleted in stearic acid (18:0, 20 ± 30%, P`0.05) and PUFA of n-6 family (linoleic acid (18:2 n-6, 35%, P`0.001) and arachidonic acid (20:4 n-6, 60%, P`0.001)) at the sn-2 position of triacylglycerols (Table  6 ). Olive oil (but not HOSO) further promoted the presence of long-chain PUFA of n-3 family (docosapentaenoic acid (22:5 n-3, b 100%, P`0.001) and docosahexaenoic acid (22:6 n-3, 60%, P`0.001)) in the sn-2 position of VLDL triacylglycerols from hypertensive patients.
Discussion
Growing evidence indicates that plasma levels of triacylglycerol-rich lipoproteins including VLDL, play an important role in the development of premature CHD (Ginsberg et al, 1995; Criqui, 1998) . The availability of triacylglycerols is the major driving force in the formation of VLDL. Therefore, dietary factors in¯uencing the supply of triacylglycerols may regulate their incorporation into VLDL and ultimately their cellular metabolic utilisation. According to previous studies, the ingestion of triacylglycerols from either olive oil or HOSO could similarly modify the plasma lipid and lipoprotein pro®les in hypertensive patients (Ruiz-Gutierrez et al, 1998a), but olive oil (and not HOSO) particularly reduced blood pressure (RuizGutierrez et al, 1996) and normalised cell membrane properties implicated in the pathogenesis of essential hypertension (Muriana et al, 1997a, b) . These observations suggest that dietary triacylglycerols may be of relevance in the metabolism of vascular cells from hypertensive patients. We have recently reported the in¯uence of olive oil and HOSO diets on the composition of VLDL triacylglycerols in healthy subjects (Ruiz-Gutierrez et al, 1998b) . Consequently, the present study was designed to determine how both MUFA diets may also in¯uence the composition of total fatty acids, triacylglycerol molecular species and fatty acids at sn-2 position of VLDL triacylglycerols in patients affected with essential hypertension (Table 1) . Olive oil and HOSO had a similar amount of MUFA, however both oils differed in their concentrations of minor fatty acids and triacylglycerol composition (Table  2) , and sn-2 positional distribution of fatty acids (Table 3) .
In addition to the low content of 20:4 n-6 in membranes of hypertensive patients when compared to that in membranes of healthy subjects (Ruiz-Gutierrez et al, 1996; Ruiz-Gutierrez et al, 1997; Villar et al, 1996) , we found that patients with untreated essential hypertension could transport more 20:4 n-6 in VLDL (Table 4) than normal (Ruiz-Gutierrez et al, 1998b) . Inclusion of olive oil in the diet of hypertensive patients resulted in accumulation of 20:4 n-6 in membranes (Ruiz-Gutierrez et al, 1996) , here we have observed a depletion of 20:4 n-6 in VLDL (Table  4) . A similar reduction in its precursor (18:2 n-6) was also found in VLDL of healthy subjects (Ruiz-Gutierrez et al, 1998b) . This interesting reverse effect of dietary olive oil in membranes of patients affected with essential hypertension was concomitant with a decrease in 18:2 n-6 and an increase in 22:5 n-6, which rather well correlates with an enhanced metabolic conversion through the elongation and desaturation of 18:2 n-6 to 20:3 n-6 and 20:4 n-6, and of 20:4 n-6 to 22:4 n-6 and 22:5 n-6. However, the content of 18:2 n-6 remained unchanged in VLDL of hypertensive patients during the period of eating the olive oil diet. It can be currently explained by some metabolic defect(s) associated to a poor formation or fast clearance of VLDL triacylglycerols containing long-chain PUFA of n-6 family. After HOSO diet, VLDL of hypertensive patients were enriched in 18:2 n-6, without any change in the content of 20:4 n-6 (Table 4 ). This effect may be related to the content of 18:2 n-6 in the oils, which was three times greater in HOSO (9% of total fats) than in olive oil.
Fatty acids are released from circulating VLDL triacylglycerols by the action of the heparin-binding enzyme, lipoprotein lipase (EC 3.1.1.34) (Wang et al, 1992) . The enzyme is tightly regulated by the composition of dietary fats (Montalto & Bensadoun, 1993) , can differentiate between substrates (Calder et al, 1994) and exhibits speci®city with respect to the position of fatty acid chains in the glycerol backbone (Wang et al, 1982) . Accordingly, the composition of VLDL triacylglycerols appears to be a determinant for the conversion of VLDL into other lipoproteins and the uptake and metabolism of triacylglycerol metabolites by cells. It was surprising to ®nd a signi®cant decrease of OOO in VLDL of hypertensive patients after both MUFA diets (Table 5) , despite OOO being the main triacylglycerol found in olive oil (46% of the total) and HOSO (63% of the total). In addition, olive oil and HOSO promoted the formation of VLDL enriched in unsaturated and saturated triacylglycerols, respectively. Our data support the concept that absorption, metabolism andaor clearance of dietary triacylglycerols may constitute nutritional Incorporation of dietary triacylglycerols V Ruiz-Gutierrez et al factors which are modi®ed in the development of human essential hypertension. In healthy subjects, we postulated the preference for long-chain PUFA in the hepatocyte triacylglycerol-synthesising pathways after olive oil intake (Ruiz-Gutierrez et al, 1998b) due to the content and positional distribution of minor fatty acids (16:0, 18:0 and 18:3 n-3) rather than of 18:1 n-9. We now propose that in hypertensive patients a diet rich in triacylglycerols from olive oil (but not from HOSO) enhances the ability of VLDL to supply cells with MUFA and PUFA. Among different pathways for the synthesis of triacylglycerols, the diacylglycerol transacylase pathway could be probably involved in the formation of dioleoyl-containing triacylglycerols after dietary olive oil, although this remains to be elucidated. Interestingly, the ingestion of olive oil (but not HOSO) promoted the presence of long-chain PUFA of n-3 family (22:5 n-3 and 22:6 n-3) in the sn-2 position of VLDL triacylglycerols from patients with untreated essential hypertension ( Table 6 ). The same was true for healthy subjects (Ruiz-Gutierrez et al, 1998b) . These results suggest that dietary olive oil may increase the availability of n-3 fatty acids to be incorporated as monoacylglycerols for the resynthesis of VLDL triacylglycerols in the liver. This is of major metabolic importance, given the recent evidence that plasma exchange of n-3 for n-6 PUFA occurs with a reduction in blood pressure of hypertensive patients (Yosefy et al, 1996) . In addition, n-3 PUFA competitively inhibit the utilisation of 20:4 n-6 for cyclooxygenase pathway and output of eicosanoids (James, 1996; Kinsella, 1994) .
Conclusions
Our data are consistent with the notion that triacylglycerols from olive oil appear to be metabolically more useful than those from HOSO for the formation of endogenous triacylglycerols that resembles a less atherogenic lipid pattern. We have demonstrated that fatty acids from dietary olive oil or HOSO are selectively incorporated within the triacylglycerol molecules of VLDL in patients with untreated essential hypertension. However, it is still unknown whether VLDL triacylglycerols produced after long-term intake of olive oil directly contribute to reduce the cardiovascular risk and to restore the abnormalities of membrane lipid bilayer in vascular cells of hypertensive patients.
